Evidence map›Paper›PMID 29793502›Full record

ArticleReproductive biology and endocrinology : RB&E2018

Deficiency of Gpr1 improves steroid hormone abnormality in hyperandrogenized mice.

Ya-Li Yang, Li-Feng Sun, Yan Yu, Tian-Xia Xiao, Bao-Bei Wang, Pei-Gen Ren, Hui-Ru Tang, Jian V Zhang

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 1α,25-Dihydroxyvitamin DCurrent issues in molecular biology · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ya-Li YangResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Li-Feng SunResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Yan YuBaoan Maternal and Child Health Care Hospital, Shenzhen, 518101, China.
Tian-Xia XiaoResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Bao-Bei WangResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Pei-Gen RenResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Hui-Ru TangPeking University Shenzhen Hospital, Shenzhen, 518035, China. 13828857955@126.com.
Jian V ZhangResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. jian.zhang@siat.ac.cn.
Shenzhen Institutes of Advanced Technology · CNMaternal and Child Health Care Hospital of Bao'an · CNPeking University Shenzhen Hospital · CNUniversity of Chinese Academy of Sciences · CN

Funding

National Natural Science Foundation of China 81771611 and 31671562Natural Science Foundation of Guangdong Province 2017A020211033Science and Technology Innovation Fund of Shenzhen 2013B021800095 and JCYJ20140415162338852Science and Technology Innovation Fund of Shenzhen JCYJ20170413165233512, JCYJ20170412140326739, JCYJ20170413165503382, JCYJ20170815123502541, JCYJ20170814175916411, and JCYJ20170307165601938Strategic Priority Research Program of CAS XDA16020702
6 · The paper itself

Abstract

backgroundPolycystic ovary syndrome (PCOS) is a complex genetic disease with multifarious phenotypes. Many researches use dehydroepiandrosterone (DHEA) to induce PCOS in pubertal mouse models. The aim of this study was to investigate the role of GPR1 in dehydroepiandrosterone (DHEA)-induced hyperandrogenized mice.

methodsPrepubertal C57BL/6 mice (25 days of age) and Gpr1-deficient mice were each divided into two groups and injected daily with sesame oil with or without DHEA (6 mg/100 g) for 21 consecutive days. Hematoxylin and eosin (H&E) staining was performed to determine the characteristics of the DHEA-treated ovaries. Real-time PCR was used to examine steroid synthesis enzymes gene expression. Granulosa cell was cultured to explore the mechanism of DHEA-induced, GPR1-mediated estradiol secretion.

resultsDHEA treatment induced some aspects of PCOS in wild-type mice, such as increased body weight, elevated serum testosterone, increased number of small, cystic, atretic follicles, and absence of corpus luteum in ovaries. However, Gpr1 deficiency significantly attenuated the DHEA-induced weight gain and ovarian phenotype, improving steroidogenesis in ovaries and estradiol synthesis in cultured granulosa cells, partially through mTOR signaling.

conclusionsIn conclusion, Gpr1 deficiency leads to the improvement of steroid synthesis in mice hyperandrogenized with DHEA, indicating that GPR1 may be a therapeutic target for DHEA-induced hyperandrogenism.

Indexed as

AnimalsCells, CulturedDehydroepiandrosteroneDisease Models, AnimalEstradiolFemaleHyperandrogenismMiceMice, Inbred C57BLMice, KnockoutPolycystic Ovary SyndromeReceptors, G-Protein-CoupledTestosteroneDehydroepiandrosteroneEstradiolGPR1 protein, mouseReceptors, G-Protein-CoupledTestosteroneEstradiolGPR1HyperandrogenismSteroidogenesis

Identifiers

PMID29793502
PMCPMC5968470
OpenAlexW2807044262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.